Hospital Acquired Infections Diagnostics Market Size And Share

  • Report Code : TIPRE00016871
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Principaux résultats et analyse des parts de marché du diagnostic des infections nosocomiales d'ici 2025-2031

Buy Now

Hospital Acquired Infections Diagnostics Market Report Hospital Acquired Infections Diagnostics Market Scope and Analysis Hospital Acquired Infections Diagnostics Market Size and Share

Hospital Acquired Infections Diagnostics Market Report Analysis

Hospital Acquired Infections Diagnostics Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Abbott Laboratories
  • AdvanDX
  • Alere Inc.
  • AstraZeneca Plc
  • Becton Dickinson and Company
  • Hologic, Inc
  • Bayer Schering Pharma LLC
  • Cepheid Inc
  • Roche AG

Regional Overview

  • Amérique du Nord
  • Europe
  • Asie-Pacifique
  • Amérique du Sud et centrale
  • Moyen-Orient et Afrique

Market Segmentation

By Produit
  • Instrument et réactifs
  • consommables
By Type de test
  • diagnostic moléculaire
  • analyse d'urine
  • immunoessai
By Application
  • dépistage des maladies
  • tests de résistance aux médicaments
By Type d'infection
  • pneumonie nosocomiale
  • infections du sang
  • infections du site opératoire
  • infections gastro-intestinales
  • autres